Leukemia | Tumor

CURE’s leukemia page is a go-to resource for oncology news and updates in the world of leukemia Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in leukemia.

How I Comforted My Friend Dying of Cancer

January 20th 2023

My friend, Kevin, was like a brother to me, so I cursed cancer when he died, yet am thankful for the time that we had together.

‘Getting Close’ To Making Stem, Bone Marrow Transplants Safer for Patients With Blood Cancer

January 16th 2023

Patients with blood cancer may develop serious infections after transplants, but a T-cell therapy may improve symptoms and side effects.

Injection Treatment for Rare Leukemia Subtype to Be Discontinued in the U.S.

January 13th 2023

The injection Lumoxiti, which was approved for patients with relapsed or refractory hairy cell leukemia, will be pulled from the U.S. market later this year, although alternative therapies are available.

On Cancer Relapses and Dealing With Depression

January 13th 2023

When I experienced an alcohol and cancer relapse, I fell into a depression. Thankfully, clinicians, loved ones and medicine helped.

At the Start of 2023, I’m Reflecting on My New Normal With Cancer

January 11th 2023

Life looks a bit different after my cancer diagnosis and the COVID-19 pandemic, making me even more grateful for the people in my life.

This Holiday, I’m Grateful for Wigs and Orangutans

December 30th 2022

I’ve been watching a YouTube channel about Borneo orangutans, and realized that these animals remind me of myself after cancer.

Finding Humor in Chemo’s Side Effects: This Too Shall Pass

December 13th 2022

From ballooning ankles to rashes, there were multiple chemotherapy side effects that I had to deal with — here’s how I did it.

Extreme Obesity May Increase Relapse Risk During Maintenance Therapy in Children With Leukemia Subtype

December 6th 2022

Children with acute lymphoblastic leukemia had a 2.4-fold greater risk of relapse if they were considered extremely obese while undergoing maintenance therapy.

FDA Approves Rezlidhia for Relapsed/Refractory Acute Myeloid Leukemia

December 1st 2022

Rezlidhia was approved for patients with acute myeloid leukemia based on study results showing that more than one-third of patients experienced a complete remission after taking the drug.

Dealing With Delirium: My Experience With Cancer Painkillers as a Recovering Addict

November 21st 2022

As a recovering addict, I was nervous about the painkillers that would come alongside my cancer treatment, but I soon learned that they would be needed.

CAR-T Cell Therapy Demonstrates Similar Survival Across Socioeconomic Status in Children With Blood Cancer

November 21st 2022

Though remission rates for children who underwent CAR-T cell therapy did not differ based on socioeconomic status, accessibility gaps remain.

When It Comes to Cancer, Are We What We Eat?

November 16th 2022

After being diagnosed with cancer 13 years ago, I began to wonder if my diet had anything to do with it — so I made some changes to eat better.

Many Thoughts Flooded My Mind When I Received a Cancer Diagnosis

November 9th 2022

“Was I OK with dying? Would I still be there for my dog? Can I still smoke?” — all these thoughts entered my mind when my oncologist told me that I had leukemia.

Liquid Biopsies May Identify Risk for Blood Cancers and Personalize Care for Patients With Solid Tumors

November 2nd 2022

Compared with tissue biopsies, liquid biopsies performed with blood samples may inform cancer teams of a patient’s increased risk for blood cancers, although all patients may not have this risk.

FDA to Prioritize Review of Oral Drug to Treat Common Type of Leukemia

October 25th 2022

The FDA granted a priority review to the oral drug quizartinib for the treatment of a form of acute myeloid leukemia, one of the more common types of leukemia.

From a Halfway House to Cancer Treatment: My Family Helped Me Live With ‘Profound Purpose’ After a Leukemia Relapse

October 25th 2022

After breaking 20 years of sobriety, I received even worse news: my leukemia had relapsed, and I’d need a bone marrow transplant. Thankfully, my family and treatment team lifted me up during this difficult time.

Embracing My Cancer Scars Because I’ve Earned Every One of Them

October 15th 2022

I’ve had leukemia for 13 years, and don’t owe anyone an explanation why my hair is short, or my face looks puffy.

First Patient Receives Investigational CAR-T Cell Therapy in Trial Assessing the Treatment for Lymphoma, Leukemia

October 14th 2022

Investigators of an expanded clinical trial have administered an investigational CAR-T cell therapy to the first patient with blood cancer.

Goodbye Leukemia, I Hope to Never See You Again

October 12th 2022

In this poem, I chronicle "Suzy Q's" experience with acute lymphoblastic leukemia.

Blood Test Results May Offer Clues to Neurotoxicity Risk After CAR-T Cell Therapy in Cancer

September 22nd 2022

Patients with blood cancer who have higher levels of neurofilament light chains — which indicate brain injury — were found to be more likely to develop neurotoxicity after CAR-T cell therapy, according to recent research.

Jane Fonda Provides a Cancer Update, Old News Clipping Helps Patient With Leukemia Benefit from the Sept. 11 Victim Fund and More

September 9th 2022

From actress Jane Fonda giving an update on her cancer, to a patient with leukemia proving he was at the Sept. 11 attacks in New York City with an old newspaper clipping, here’s what’s happening in the cancer space this week.

Robin Roberts to Step Away from “GMA,” Former NFL Player Dies of Cancer and More

September 2nd 2022

From “Good Morning America” host Robin Roberts stepping away from the show after her partner finished breast cancer radiation to a former Tampa Bay Buccaneer dying of leukemia, here is what’s happening in the cancer space this week.

Early Findings of Novel Agent Show Promise in Treating Rare Blood Cancer

August 31st 2022

Patients with blastic plasmacytoid dendritic cell neoplasms can enroll in the ongoing CADENZA trial, which is investigating the safety and efficacy of the novel agent pivekimab sunirine in patients with the rare blood cancer.

FDA Lifts Partial Hold on Blood Cancer Trial, Patient Enrollment Allowed to Continue

August 31st 2022

The FDA’s decision allows patients with relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndrome — types of blood cancer — to continue enrolling on the TakeAim Leukemia trial.

FDA Stops Study of Novel Blood Cancer Drug

August 23rd 2022

The Food and Drug Administration put a full clinical hold on a study of the novel drug FHD-286 in patients with acute myelogenous leukemia and myelodysplastic syndrome after study data showed an increase in a potentially fatal side effect.

First Patient Receives Investigational Cancer Drug-Combination for Relapsed/Refractory Acute Myeloid Leukemia

August 22nd 2022

Adding the investigational cancer drug lanraplenib to Xospata, if found to be effective, may broaden treatment options for patients with relapsed/refractory FLT3-mutated acute myeloid leukemia.

BBC’s ‘EastEnders’ Star Announces Cancer Diagnosis, Leukemia Survivor Embarks on Nation-Wide Bike Ride to Diversify Transplantation Donors and More

August 12th 2022

From “EastEnders” star Samantha Womack announcing her breast cancer diagnosis in a tribute to Olivia Newton-John to a famous fashion designer’s death from liver cancer, here’s what’s happening in the oncology space this week.

Crying Over a Movie, Cancer and Lost Innocence

August 11th 2022

“Love Story,” the story about a young woman who falls in love and then dies of cancer, affects me differently now than it did when I was a teenager and no experience with either love or cancer.

Leukemia Survivor Meets Country Music Singer Luke Combs, Sarcoma Nonprofit to Honor Minecraft YouTube Celebrity Technoblade and More

August 5th 2022

From the late YouTuber “Technoblade” being honored by the Sarcoma Foundation of America to a country singer making a leukemia survivor’s dreams come true, here’s what’s happening in the cancer space this week.

FDA Approves Tablet Version of Calquence to Treat Multiple Blood Cancers

August 5th 2022

The tablet version of Calquence, which was approved by the FDA for the treatment of chronic lymphocytic leukemia, small lymphocytic leukemia and relapsed/refractory mantle cell lymphoma, may be taken alongside other drugs to reduce gastric-related side effects.

NEXT PAGE
PREVIOUS PAGE